Skip to main content

Childrens Robitussin Nighttime Cough Long-Acting DM

NDC 0031-8692 · Haleon US Holdings LLC

Generic namechlorpheniramine maleate, dextromethorphan hydrobromide
Dosage formSOLUTION
RouteORAL
Active ingredient(s)CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE
Strength2; 15 mg/10mL; mg/10mL
Pharmacologic classHistamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]
Marketing categoryOTC MONOGRAPH DRUG

Packages

0031-8692-13 — 1 BOTTLE in 1 CARTON (0031-8692-13) / 118 mL in 1 BOTTLE

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0031-0100 — acetaminophen, dextromethorphan hydrobromide, guaifenesin, 0031-2097 — dextromethorphan HBr, guaifenesin, 0031-2098 — dextromethorphan HBr, guaifenesin, 0031-8655 — dextromethorphan polistirex, 0031-8693 — chlorpheniramine maleate, dextrometrorphan HBr, 0031-8694 — dextromethorphan hydrobromide, 0031-8702 — dextromethorphan hydrobromide and guaifenesin, 0031-8715 — dextromethorphan hydrobromide, guaifenesin, 0031-8716 — dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride, 0031-8718 — dextromethorphan hydrobromide, doxylamine succinate, 0031-8719 — dextromethorphan hydrobromide and guaifenesin, 0031-8725 — dextromethorphan polistirex, 0031-8726 — dextromethorphan polistirex, 0031-8739 — dextromethorphan hbr, guaifenesin, 0031-8742 — dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride, 0031-8743 — dextromethorphan hydrobromide, 0031-8744 — acetaminophen, dextromethorphan hydrobromide, and doxylamine succinate, 0031-8750 — acetaminophen, dextromethorphan hydrobromide, 0031-8751 — acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride, 0031-8753 — dextromethorphan polistirex, +2124 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.